Abstract
Background: Mycobacterium abscessus is the most pathogenic and drug-resistant rapid-growing mycobacterium. Clarithromycin or azithromycin are the only regular oral antimycobacterial agents that have an effect on M. abscessus. We tried to detect the clarithromycin-resistant strains from the clinical isolates of M. abscessus. Methods: We tried to isolate the clarithromycin-resistant strains from 220 clinical isolates of M. abscessus by performing using reverse hybridization assay (RHA) and the broth microdilution test (BMT). Results: Seven resistant strains (3.2%) from all the tested clinical isolates were detected by BMT. Three of these resistant strains were also detected by RHA and it was confirmed that they had point mutants. Conclusion: These results showed that clarithromycin resistance in M. abscessus clinical isolates is related to a point mutation and other unknown mechanisms.
Original language | English |
---|---|
Pages (from-to) | 422-426 |
Number of pages | 5 |
Journal | Tuberculosis and Respiratory Diseases |
Volume | 64 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2008 Jun |
Externally published | Yes |
Keywords
- 23S rRNA
- Broth microdilution test
- Clarithromycin
- Mycobacterium abscessus
- Reverse hybridization assay
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Infectious Diseases